Actively Recruiting
Evaluation of Buckwheat Husk Extract on Cardiovascular Disease Risk Factors A Double-Blind, Randomized Study with Daily Supplement Intake for Two Months
Led by TCI Co., Ltd. · Updated on 2025-01-09
60
Participants Needed
1
Research Sites
222 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of buckwheat husk extract on risk factors for cardiovascular diseases in adults. This study aims to understand how this extract might influence blood pressure and other related health markers. The trial is double-blind and randomized to ensure unbiased results. Participants are assigned to consume either buckwheat husk extract or a placebo, taking one sachet daily for two months. The study monitors changes in systolic and diastolic blood pressure at the start, after 28 days, and at the end of 56 days. Throughout the study, doctors evaluate clinical signs related to cardiovascular disease. During the study, participants will have their blood pressure measured on three occasions. Doctors will assess cardiovascular health and monitor for any changes or side effects. Participants are expected to cooperate with the daily supplement intake and follow guidelines related to pregnancy and contraception during the trial period.
CONDITIONS
Official Title
The Efficacy Evaluation of Buckwheat Husk Extract on Cardiovascular Disease Risk Factors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 20 to 65 years, male or non-pregnant female willing to sign consent
- Systolic blood pressure between 121 and 139 mmHg and diastolic blood pressure between 81 and 89 mmHg
- Non-pregnant and willing to use contraception during the trial
- No history of organ transplantation, epilepsy or convulsions, liver or kidney disease, malignant tumor, endocrine disease, mental disease, alcohol or drug abuse, or other major organic diseases according to medical history
You will not qualify if you...
- Pregnant women
- History of organ transplantation, epilepsy or convulsions, liver or kidney disease, malignant tumors, endocrine diseases, mental illness, alcohol or drug abuse, or other major organic diseases according to medical history
- Individuals who have undergone major surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Taiwan University Hospital
Taipei, Taiwan, 114
Actively Recruiting
Research Team
S
Shyr-Chyr Chen
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here